Quantcast

Latest Inflammatory breast cancer Stories

2009-12-11 14:06:48

But second study finds a subset of patients who may not benefit Chemotherapy added to tamoxifen can improve outcomes for postmenopausal breast cancer patients, according to a landmark study by the Southwest Oncology Group. But a related study presented today at the 2009 San Antonio Breast Cancer Symposium finds that a multigene test on tumors can identify a subset of patients who may not benefit from that chemotherapy. Both studies were led by Dr. Kathy Albain, of Loyola University Health...

2009-12-11 10:59:21

But a Subset of Patients May not Need Chemo Chemotherapy generally improves survival in postmenopausal breast cancer patients, according to a landmark study led by Dr. Kathy Albain of Loyola University Health System. However a second study, also headed by Albain, found that a multigene test on a breast tumor can identify a subset of women who may not benefit from chemotherapy. The related studies were published simultaneously online, ahead of print, Dec. 10 in the journals Lancet and Lancet...

2009-12-10 17:30:00

SAN ANTONIO, Dec. 10 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that The Lancet Oncology published positive results from a study of Oncotype DX(®) in postmenopausal women with node-positive, estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group (SWOG), a National Cancer Institute-supported clinical trials cooperative group. The Lancet Oncology published these results online as an "early release" to...

2009-12-08 07:30:00

HUNTINGTON BEACH, California and AMSTERDAM, December 8 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, announced today that it will be presenting six studies focusing on MammaPrint(R) at the 2009 San Antonio Breast Cancer Symposium (SABCS), one of the premiere conferences in breast cancer research worldwide. The SABCS will take place December 9-13, at the Henry B. Gonzalez Convention Center in San Antonio, Texas, USA. Agendia's studies to be presented at the...

2009-12-02 13:05:17

Even when informed about risks, benefits, only 6% would take drug Even when women at high-risk of breast cancer are well-informed about the risks and benefits of using the drug tamoxifen for prevention, only 6 percent said they were likely to take it. Researchers at the University of Michigan Comprehensive Cancer Center created a decision aid designed to inform women about the risks and benefits associated with tamoxifen, a drug that was first used to stop breast cancer from returning and has...

2009-10-28 07:00:00

IRVINE, Calif., Oct. 28 /PRNewswire/ -- Although Breast Cancer Awareness Month is coming to an end, smart women know that taking care of their health is important throughout the year. What's more, women age 25 and older now have a tool to help them understand their potential risk for breast cancer. Based on the same science as the PAP test for cervical cell changes, HALO® is the only FDA-cleared risk assessment tool for non-hereditary breast cancer. HALO can help...

2009-10-26 15:26:00

For women just diagnosed with breast cancer, one of the important decisions confronting them is whether to have a lumpectomy or mastectomy. A diagnosis of breast cancer will affect one in every eight women in the United States, according to the American Cancer Society, causing them to have to decide quickly about treatment. Most studies investigating how women make this choice have surveyed women months and sometimes even years after their decision was made. Recently, however, the publication...

2009-09-28 15:26:00

Estrogen levels following menopause may impact risk of joint pain caused by drugs; electro-acupuncture proves helpful for alleviating symptoms Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of Pennsylvania School of Medicine research, however, has uncovered patterns that may help clinicians identify and...

2009-09-15 12:38:00

ROCKVILLE, Md., Sept. 15 /PRNewswire-USNewswire/ -- Three drugs, including tamoxifen, reduce a woman's chance of getting breast cancer, but each drug carries distinct potential harms of its own, according to a new report from HHS' Agency for Healthcare Research and Quality. Drugs to reduce the risk of breast cancer can be prescribed to women with a family history of breast cancer or other risk factors, but prescribing practices vary widely. The comparative effectiveness review found that...

2009-09-14 22:32:10

Drugs used to lower the risk of breast cancer in women have the side effect of increasing the likelihood of blood clots, researchers in Oregon say. The study, published in the current issue of Annals of Internal Medicine, examined the effects of tamoxifen, raloxifene and tibolone reduce the risk of invasive breast cancer by 30 percent to 68 percent. But it also found tamoxifen and raloxifene increase the chance of blood clots by 60 percent to 90 percent, and that tiboline, which is not on the...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related